How big is Veradigm, Inc.?

As of Jun 18, Veradigm, Inc. has a market capitalization of 1,424.30 million, with net sales of 601.70 million and a net profit of 5.78 million over the latest four quarters.

Market Cap: As of Jun 18, Veradigm, Inc. has a market capitalization of 1,424.30 million, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Veradigm, Inc. reported net sales of 601.70 million and a net profit of 5.78 million.<BR><BR>Balance Sheet Snapshot: As of December 2022, the company had shareholder's funds amounting to 1,017.50 million and total assets of 1,504.72 million.

What does Veradigm, Inc. do?

Veradigm, Inc. is a healthcare IT solutions provider in the small-cap market, reporting net sales of $156 million and a net loss of $27 million as of December 2022. The company has a market cap of $1.42 billion and key metrics include a P/E ratio of 142 and a return on equity of 0.99%.

Overview:<BR>Veradigm, Inc. is a healthcare information technology solutions provider operating in the Software Products industry within the small-cap market.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 156 Million (Quarterly Results - Dec 2022) <BR>Most recent Net Profit: -27 Million (Quarterly Results - Dec 2022) <BR>Market-cap: USD 1,424.30 Million (Small Cap) <BR><BR>Key Metrics:<BR>P/E: 142.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.24 <BR>Return on Equity: 0.99% <BR>Price to Book: 1.40 <BR><BR>Contact Details:<BR>Address: 222 Merchandise Mart Plz Ste 2024, CHICAGO IL: 60654-1010 <BR>Tel: 1 312 5061200 <BR>Website: http://www.allscripts.com

Who are in the management team of Veradigm, Inc.?

As of March 2022, Veradigm, Inc.'s management team includes Independent Chairman Mr. Michael Klayko, CEO Mr. Paul Black, and Directors Beth Altman, Carol Zierhoffer, Mara Aspinall, P. Gregory Garrison, and Jonathan Judge. The team features a blend of executive leadership and independent directors.

As of March 2022, the management team of Veradigm, Inc. includes the following individuals:<BR><BR>- Mr. Michael Klayko, who serves as the Independent Chairman of the Board.<BR>- Mr. Paul Black, the Chief Executive Officer and a Director.<BR>- Beth Altman, who is a Director.<BR>- Ms. Carol Zierhoffer, also a Director.<BR>- Ms. Mara Aspinall, serving as an Independent Director.<BR>- Mr. P. Gregory Garrison, who is an Independent Director.<BR>- Mr. Jonathan Judge, another Independent Director.<BR><BR>This team comprises a mix of executive leadership and independent directors, contributing to the governance and strategic direction of the company.

Should I buy, sell or hold Veradigm, Inc.?

Is Veradigm, Inc. overvalued or undervalued?

As of July 8, 2024, Veradigm, Inc. is considered overvalued with a high P/E ratio of 142 and significant underperformance compared to the S&P 500, leading to a valuation downgrade from expensive to does not qualify.

As of 8 July 2024, the valuation grade for Veradigm, Inc. has moved from expensive to does not qualify, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its high P/E ratio of 142, an EV to EBIT of 56.85, and a Price to Book Value of 1.40, which are all considerably elevated compared to its peers. For instance, NextGen Healthcare, Inc. has a fair valuation with a P/E ratio of -1604.29 and an EV to EBITDA of 35.23, suggesting that Veradigm's metrics are not justified in the current market context.<BR><BR>The stock has significantly underperformed against the S&P 500, with a year-to-date return of -52.31% compared to the S&P 500's 12.22%, and a three-year return of -71.45% versus the S&P 500's 70.41%. This stark contrast reinforces the notion that Veradigm is overvalued in its current state.

Is Veradigm, Inc. technically bullish or bearish?

As of September 5, 2025, Veradigm, Inc. shows a mildly bearish trend with key indicators like a bearish daily moving average and monthly MACD, despite some weekly bullish signals, and has underperformed the S&P 500 with a year-to-date return of -52.31%.

As of 5 September 2025, the technical trend for Veradigm, Inc. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators driving this sentiment including a bearish daily moving average and a bearish monthly MACD. Although the weekly MACD and KST are mildly bullish, they are overshadowed by the overall bearish signals in the monthly timeframe. Additionally, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -52.31% compared to the S&P's 12.22%.